Edition:
United Kingdom

MDxHealth SA (MDXH.BR)

MDXH.BR on Brussels Stock Exchange

3.48EUR
10:03am GMT
Change (% chg)

€0.09 (+2.50%)
Prev Close
€3.39
Open
€3.45
Day's High
€3.48
Day's Low
€3.44
Volume
45,933
Avg. Vol
218,235
52-wk High
€5.78
52-wk Low
€2.89

Select another date:

Thu, Jan 18 2018

BRIEF-MDxHealth ‍Develops Blood Test For Prostate Cancer Patients​

* ‍DEVELOPS BLOOD TEST TO GUIDE PRECISION-TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER PATIENTS​

BRIEF- MDxHealth Lowers Guidance For 2017

* HAS FACED TIMING ISSUES IN OBTAINING BILLABLE CASES FROM CONTRACTED CONFIRMMDX CUSTOMERS AND FROM POST-MARKETING STUDIES

BRIEF-MDxHealth teams up with Ferrer for distribution of its prostate cancer test SelectMDx in Spain

* REG-MDXHEALTH TEAMS UP WITH PHARMACEUTICAL COMPANY FERRER FOR DISTRIBUTION OF ITS PROSTATE CANCER TEST SELECTMDX IN SPAIN

BRIEF-MDX Pcl posts ‍qtrly net profit of 86.1 mln baht

* ‍Qtrly net profit 86.1 million baht versus 19.8 million baht Source text for Eikon: Further company coverage:

BRIEF-MDxHealth 9M total revenue at 30.5 million dollars

* 9M (NOT Q3) NET LOSS $‍​7.4 MILLION VERSUS LOSS OF $10.3 MILLION YEAR AGO

BRIEF-MDxhealth enters distribution agreement with Unilabs for SelectMDx

* ‍MDXHEALTH ENTERS INTO DISTRIBUTION AGREEMENT WITH UNILABS FOR SELECTMDX FOR PROSTATE CANCER ​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-MDxHealth opens new laboratory in the Netherlands

* MDXHEALTH OPENS NEW SERVICE AND RESEARCH LABORATORY IN THE NETHERLANDS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-MDxHealth appoints Michael K. Brawer as Chief Medical Officer‍​

* ANNOUNCES APPOINTMENT OF MICHAEL K. BRAWER, MD AS CHIEF MEDICAL OFFICER‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-MDxHealth H1 EBITDA rises to 1.4 million dollars

* H1 ‍TOTAL REVENUE OF $24.3 MILLION, UP 87% FROM $12.9 MILLION IN 2016​

Select another date: